{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:04:56Z","timestamp":1749038696878},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2143-3","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:02:17Z","timestamp":1562025737000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Central serous retinopathy associated with topical oral corticosteroid use: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Preston","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan C.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley Day","family":"Ghafoori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Armitage","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"issue":"3","key":"2143_CR1","first-page":"131","volume":"46","author":"D Hussain","year":"1998","unstructured":"Hussain D, Gass JD. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1998;46(3):131\u20137.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"2143_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","volume":"7","author":"LA Yannuzzi","year":"1987","unstructured":"Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987;7(2):111\u201331.","journal-title":"Retina"},{"issue":"1","key":"2143_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00006982-200001000-00020","volume":"20","author":"AM Thoelen","year":"2000","unstructured":"Thoelen AM, Bernasconi PP, Schmid C, et al. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000;20(1):98\u20139.","journal-title":"Retina"},{"issue":"6","key":"2143_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00937280","volume":"235","author":"E Zamir","year":"1997","unstructured":"Zamir E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis. Graefes Arch Clin Exp Ophthalmol. 1997;235(6):339\u201344.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2143_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0002-9394(74)90667-9","volume":"77","author":"LC Chumbley","year":"1974","unstructured":"Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974;77(2):158\u201360.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"2143_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","volume":"109","author":"CA Carvalho-Recchia","year":"2002","unstructured":"Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109(10):1834\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"2143_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00164568","volume":"60","author":"T Harada","year":"1985","unstructured":"Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol. 1985;60(1):37\u201344.","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"2143_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00006982-199805000-00020","volume":"18","author":"LY Kao","year":"1998","unstructured":"Kao LY. Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection. Retina. 1998;18(5):479\u201381.","journal-title":"Retina"},{"issue":"10","key":"2143_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0161-6420(97)30082-7","volume":"104","author":"R Haimovici","year":"1997","unstructured":"Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104(10):1653\u201360.","journal-title":"Ophthalmology"},{"issue":"6","key":"2143_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/archopht.122.6.926","volume":"122","author":"CR Baumal","year":"2004","unstructured":"Baumal CR, Martidis A, Truong SN. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis. Arch Ophthalmol. 2004;122(6):926\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2143_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/0301-4738.16181","volume":"53","author":"LK Mondal","year":"2005","unstructured":"Mondal LK, Sarkar K, Datta H, et al. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid. Indian J Ophthalmol. 2005;53(2):132\u20134.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2143_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00006982-200406000-00027","volume":"24","author":"CF Fernandez","year":"2004","unstructured":"Fernandez CF, Mendoza AJ, Arevalo JF. Central serous chorioretinopathy associated with topical dermal corticosteroids. Retina. 2004;24(3):471\u20134.","journal-title":"Retina"},{"issue":"5","key":"2143_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/09546634.2015.1136049","volume":"27","author":"LY Chan","year":"2016","unstructured":"Chan LY, Adam RS, Adam DN. Localized topical steroid use and central serous retinopathy. J Dermatol Treat. 2016;27(5):425\u20136.","journal-title":"J Dermatol Treat"},{"key":"2143_CR14","first-page":"918","volume":"10","author":"N Ezra","year":"2011","unstructured":"Ezra N, Taban M, Behroozan D. Central Serous Chorioretinopathy Associated With Topical Corticosteroids in a Patient With Psoriasis. J Drugs Dermatol. 2011;10:918\u201321.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"2143_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/archopht.122.5.784","volume":"122","author":"P Karadimas","year":"2004","unstructured":"Karadimas P, Kapetanios A, Bouzas EA. Central Serous Chorioretinopathy After Local Application of Glucocorticoids for Skin Disorders. Arch Ophthalmol. 2004;122(5):784\u20136.","journal-title":"Arch Ophthalmol"},{"key":"2143_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/ijdr.IJDR_694_16","volume":"29","author":"S George","year":"2018","unstructured":"George S, Balan A. A potential side effect of oral topical steroids: Central serous chorioretinopathy. Indian J Dent Res. 2018;29:107\u20138.","journal-title":"Indian J Dent Res"},{"key":"2143_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","volume":"47","author":"EA Bouzas","year":"2002","unstructured":"Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431\u201348.","journal-title":"Surv Ophthalmol"},{"key":"2143_CR18","first-page":"1153","volume-title":"Retina","author":"AP Ciardella","year":"2001","unstructured":"Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central serous chorioretinopathy. In: Ryan SJ, editor. Retina. St Louis: Mosby Inc; 2001. p. 1153\u201381. ed 3."},{"key":"2143_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00000658-197302000-00017","volume":"177","author":"HP Ehrlich","year":"1973","unstructured":"Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg. 1973;177:222\u20137.","journal-title":"Ann Surg"},{"key":"2143_CR20","first-page":"848","volume":"80","author":"CP Basti","year":"1987","unstructured":"Basti CP. Regulation of cation transport by low doses of glucocorticoids. J Clin Invest. 1987;80:848\u201356.","journal-title":"J Clin Invest"},{"issue":"9","key":"2143_CR21","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/IAE.0b013e318156db8a","volume":"27","author":"SS Mudvari","year":"2007","unstructured":"Mudvari SS, Goff MJ, Fu AD, et al. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina. 2007;27(9):1168\u201373.","journal-title":"Retina"},{"key":"2143_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40942-018-0137-8","volume":"4","author":"I Chatziralli","year":"2018","unstructured":"Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: A review of the literature. Int J Retin Vitr. 2018;4:33.","journal-title":"Int J Retin Vitr"},{"key":"2143_CR23","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","volume":"35","author":"E Bousquet","year":"2015","unstructured":"Bousquet E, et al. Spironolactone for nonresolving central serous chorioretinopathy: A randomized controlled crossover study. Retina. 2015;35:2505\u201315. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000000614\n                    \n                  .","journal-title":"Retina."},{"key":"2143_CR24","unstructured":"Orellana J. Therapy of Central Serous Chorioretinopathy and Diabetic Macular Edema Using NSAIDs. Retin Physician. 2006; \n                    https:\/\/www.retinalphysician.com\/issues\/2006\/nov-dec\/therapy-of-central-serous-chorioretinopathy-and-di\n                    \n                  . Accessed 7 Aug 2018."},{"key":"2143_CR25","unstructured":"Gass JD. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(3 Pt 1):456\u201367."},{"issue":"5","key":"2143_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/IAE.0b013e3181c9699c","volume":"30","author":"M Inoue","year":"2010","unstructured":"Inoue M, Kadonosono K, Watanabe Y, et al. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Retina. 2010;30(5):733\u20138.","journal-title":"Retina"},{"issue":"7","key":"2143_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00417-010-1581-9","volume":"249","author":"JW Lim","year":"2011","unstructured":"Lim JW, Kim MU. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):969\u201374. \n                    https:\/\/doi.org\/10.1007\/s00417-010-1581-9\n                    \n                  . Epub 2010 Dec 8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"2143_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/112067219200200301","volume":"2","author":"LA Yannuzzi","year":"1992","unstructured":"Yannuzzi LA, Slakter JS, Kaufman SR, et al. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992;2(3):103\u201314.","journal-title":"Eur J Ophthalmol"},{"key":"2143_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1600-0714.2011.01087.x","volume":"41","author":"EM Varoni","year":"2012","unstructured":"Varoni EM, Molteni A, Sardella A, Carrassi A, Di Candia D, Gigli F, Lodi F, Lodi G. Pharmacokinetics study about topical clobetasol on oral mucosa. J Oral Pathol Med. 2012;41:255\u201360. \n                    https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01087.x\n                    \n                  .","journal-title":"J Oral Pathol Med"},{"key":"2143_CR30","unstructured":"Routes AE, Drug absorption, distribution and elimination Pharmacokinetics. \n                    http:\/\/www.columbia.edu\/itc\/gsas\/g9600\/2004\/GrazianoReadings\/Drugabs.pdf\n                    \n                  .\u00a0Accessed 5 May 2019."},{"issue":"6","key":"2143_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0030-4220(90)90349-W","volume":"69","author":"JM Plemons","year":"1990","unstructured":"Plemons JM, Rees TD, Zachariah NY. Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol. 1990;69(6):688\u201393. \n                    https:\/\/doi.org\/10.1016\/0030-4220(90)90349-W","journal-title":"Oral Surg Oral Med Oral Pathol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2143-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:05:10Z","timestamp":1593561910000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2143"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2143-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was sent to the University of Texas at Austin Institutional Review Board and need for further approval was waived, as the information was analyzed in a retrospective manner and had no effect on treatment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}